Zepbound 12.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FJJ5V
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,649
Award facts
- Contract value 100% obligated
- $17,648.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $17,648.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Zepbound 12.5 mg/0.5 ml pen injectors on January 20, 2026, with completion targeted for January 21, 2026. The contract was competitively awarded with no set-aside designation and identifies Conshohocken, Pennsylvania as the place of performance, which serves as the company's corporate headquarters. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a single-award IDC valued at $999.99 million through December 2031 that provides comprehensive pharmaceutical and medical supply support to military healthcare programs globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc., regularly fulfills federal medical procurement requirements across diverse therapeutic domains including diabetes management, specialty medications, and critical care materials. The delivery order for Zepbound—a glucagon-like peptide-1 receptor agonist used for weight management—reflects the company's capability to supply brand-name pharmaceutical products to support Defense Health Agency and military treatment facilities. As a critical vendor in the federal pharmaceutical supply chain, AmerisourceBergen has demonstrated consistent competitiveness in open competition for medical commodities serving the Department of Defense healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FJJ5V?
SPE2DR26FJJ5V was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 20, 2026.
How much is contract SPE2DR26FJJ5V worth?
The government has obligated $17,649 on SPE2DR26FJJ5V.
Is contract SPE2DR26FJJ5V an order under another contract?
Yes. SPE2DR26FJJ5V is a delivery order under SPE2DR25D1106, an indefinite delivery contract.
Was contract SPE2DR26FJJ5V competed?
The extent of competition for SPE2DR26FJJ5V was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award